MTOR and neoplasm: SRMS kinase inhibition activates autophagy and inhibits tumor growth, and can be accomplished by using FDA-approved tyrosine kinase inhibitor Ibrutinib.223 In gastric cancer, Salidroside decreases the phosphorylation of PI3K/AKT/mTOR and induces apoptosis and protective autophagy.